ACE Veterans Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill requires the Department of Veterans Affairs (VA) to allow veterans enrolled in the VA healthcare system to receive a full-year supply of contraceptive pills, patches, rings, and other contraceptive products when prescribed. VA medical providers must notify veterans of this option when prescribing contraceptives.
Who Benefits and How
Veterans who use contraceptives benefit by gaining access to a full-year supply at once, reducing the need for frequent refills, pharmacy visits, and potential gaps in coverage. This is particularly beneficial for veterans in rural areas or those with limited transportation. Pharmaceutical companies that manufacture contraceptives may see increased demand from VA bulk purchasing.
Who Bears the Burden and How
The VA healthcare system bears administrative and inventory management costs for stocking and dispensing larger quantities. Taxpayers may face slightly higher upfront costs for prescription fulfillment, though this may be offset by reduced administrative costs from fewer refills.
Key Provisions
- Veterans can elect to receive a 12-month supply of prescribed contraceptive products
- VA providers must inform veterans of this full-year supply option
- Covers all FDA-approved contraceptive drugs, devices, and biological products
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Requires the Department of Veterans Affairs to allow enrolled veterans to receive a full-year supply of contraceptive products when prescribed by a VA medical provider.
Key Policy Areas
Healthcare, Veterans Affairs
Primary Purpose
Requires the Department of Veterans Affairs to allow enrolled veterans to receive a full-year supply of contraceptive products when prescribed by a VA medical provider.
Policy Domains
Full Bill - Veterans Contraceptive Access
Identified Gains
Contextual inference, no direct clause citation- Veterans enrolled in VA healthcare
- Veterans in rural areas
- Pharmaceutical manufacturers of contraceptives
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- VA healthcare system
- Federal budget/taxpayers
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMs. Duckworth (for herself, Ms. Hirono, Mr. Fetterman, Mrs. Murray, …
Read twice and referred to the Committee on Veterans' Affairs.
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → Secretary of Veterans Affairs
- "the_department"
- → Department of Veterans Affairs
Key Definitions
Terms defined in this bill
Any drug, device, or biological product intended for use in the prevention of pregnancy, whether specifically intended to prevent pregnancy or for other health needs, that is approved, cleared, authorized, or licensed under section 505, 510(k), 513(f)(2), 515, or 564 of the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act.
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology